BioLegend
BioLegend is a San Diego-based life science reagent company that develops and manufactures antibodies, recombinant proteins, immunoassays, and single-cell proteogenomics tools for academic, pharmaceutical, clinical diagnostics, and cell therapy manufacturing customers in 90+ countries.
- Company typePrivate
- Founded2002
- HeadquartersSan Diego, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioLegend does
BioLegend, headquartered in San Diego, California, is a life science reagent manufacturer specializing in antibody-based products, recombinant proteins, immunoassays, and cell separation tools for biomedical research and clinical applications. Its core catalog spans flow cytometry reagents (including Brilliant Violet™ and StarBright™ dyes), MojoSort™ magnetic cell separation kits, LEGENDplex™ multiplex immunoassays, ELISA kits, recombinant cytokines and growth factors, and the TotalSeq™ family of oligonucleotide-conjugated antibodies that bridge protein detection with single-cell RNA/DNA sequencing on 10x Genomics, Illumina, and Mission Bio platforms. The company also operates a GMP-compliant Cell-Vive™ ancillary materials portfolio for cell and gene therapy bioprocessing and a clinical IVD/ASR product line under ISO 13485:2016 quality systems.
The business operates a hybrid go-to-market combining direct e-commerce (biolegend.com and regional storefronts), field sales representatives for bulk and custom work, and an authorized distributor network covering more than 90 countries, with wholly-owned regional entities in the UK, Netherlands, Japan, China, and Germany. Revenue is generated primarily through one-time catalog sales of catalog antibodies, proteins, and kits, supplemented by professional services (custom conjugation, custom immunoassay development) and managed services (GMP contract manufacturing). Pricing is unit-based for standard SKUs and quote-based for custom and bulk orders. BioLegend has been a wholly-owned subsidiary of Revvity — the S&P 500 health science company spun off from PerkinElmer in 2023 with $2.7B+ in 2023 revenue — since the 2021 acquisition, and serves pharmaceutical/biotech firms, academic institutions, government research programs, clinical laboratories, and biopharmaceutical manufacturers across more than 190 end markets.
BioLegend firmographics
Firmographics- Name
- BioLegend
- Legal name
- BioLegend, Inc.
- Website
- https://biolegend.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- BioLegend is a San Diego-based life science reagent company that develops and manufactures antibodies, recombinant proteins, immunoassays, and single-cell proteogenomics tools for academic, pharmaceutical, clinical diagnostics, and cell therapy manufacturing customers in 90+ countries.
- Ownership category
- akta.pro rank
BioLegend industry classification
Industry- Product category
- Life Science Reagents
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Cell Therapy Enabling Technologies (gene editing, cell engineering, delivery methods) (HLAAABAL)
Keywords
Where BioLegend is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
BioLegend business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Research Antibodies and Reagents: Sale of catalog antibodies and reagents for research applications including flow cytometry, immunohistochemistry, immunofluorescence, Western blot, and other applications. Products are sold in various formats (purified, conjugated, lyophilized) with different fluorophore options.
- Recombinant Proteins and Cytokines: Sale of bioactive recombinant proteins including cytokines, growth factors, chemokines, and enzymes for cell culture and research applications.
- Immunoassays (ELISA and LEGENDplex™): Multiplex and singleplex immunoassay kits for detecting analytes in biological samples. Includes pre-defined panels and custom configurations.
- Custom Reagents and Conjugation Services: Custom antibody conjugations, cocktail formulations (including fluorophore and TotalSeq™ options), custom recombinant proteins and antibodies, and custom ELISA/LEGENDplex configurations.
- Custom Manufacturing Services: Contract manufacturing for research-grade and GMP-compliant materials including recombinant proteins, monoclonal/recombinant antibodies, cell culture media, and scalable production for bioprocessing applications.
- Clinical Diagnostics (IVD and ASR): In Vitro Diagnostic products and Analyte Specific Reagents for clinical laboratory use in immunophenotyping and diagnostic applications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard catalog antibodies - purified and conjugated formats |
| Unit Pricing | Per order | Shipping fees by product type and temperature requirements |
| Other | Multi-year contract | Custom solutions and bulk orders |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
BioLegend product offering
Product offeringCore offering
BioLegend develops, manufactures, and distributes a catalog of thousands of antibody-based reagents for life science research, including flow cytometry antibodies, recombinant proteins (cytokines, growth factors, chemokines), multiplex immunoassays (LEGENDplex™), ELISA kits, and MojoSort™ magnetic cell separation products. The portfolio is anchored by proprietary platforms such as TotalSeq™ oligo-conjugated antibodies for single-cell proteogenomics, Flex-T™ MHC tetramers for antigen-specific T cell detection, and GMP-grade Cell-Vive™ ancillary materials for cell therapy bioprocessing, complemented by custom conjugation services and contract manufacturing for research and clinical applications.
Product overview
BioLegend is a life science reagent company offering a comprehensive portfolio of research tools organized around antibody-based products, immunoassays, and custom services. The core portfolio includes thousands of conjugated and unconjugated antibodies for flow cytometry, microscopy, Western blot, and immunohistochemistry applications, supplemented by recombinant proteins (cytokines, growth factors, chemokines), magnetic cell separation kits (MojoSort™), multiplex bead-based immunoassays (LEGENDplex™), and ELISA kits. TotalSeq™ oligo-conjugated antibodies enable proteogenomics workflows combining protein detection with single-cell RNA sequencing. The company provides GMP-grade Cell-Vive™ products for cell therapy bioprocessing and clinical IVD/ASR reagents for diagnostic laboratories. Custom solution capabilities include conjugation services, lyophilized antibody cocktails (XerosFlow™), custom immunoassay development, and contract manufacturing. Supporting web tools include spectral analyzers, panel builders, brightness indices, and a cloud-based Multiomics Analysis Software (MAS) for data analysis. BioLegend operates as part of Revvity and maintains ISO 13485:2016 compliant quality systems.
Differentiator
Problem solved
Functional benefit
Products and services
- Antibodies and Reagents Primary antibodies and reagents for flow cytometry, immunohistochemistry, immunofluorescence, Western blot, and other immunological applications, offered in purified and conjugated formats with various fluorophore options.
- MojoSort™ Magnetic Cell Separation Magnetic cell separation system using negative selection to isolate untouched cells for downstream flow cytometry, cell culture, and molecular biology applications.
- Recombinant Proteins, Cytokines, Growth Factors Bioactive recombinant proteins including cytokines, growth factors, chemokines, and enzymes validated in functional bioassays for cell culture and research applications.
- Ultra-LEAF™ and GoInVivo™ Antibodies Low endotoxin, azide-free purified bulk antibodies for in vivo research, cell culture, functional assays, and bioprocessing applications.
- TotalSeq™ Oligo-Conjugated Antibodies Oligonucleotide-conjugated antibodies available in TotalSeq-A, B, C, and D formats for simultaneous protein and RNA detection in single-cell RNA sequencing, high-parameter protein detection (PhenoCyte), and single-cell DNA analysis workflows.
- LEGENDplex™ Multiplex Immunoassays Bead-based multiplex assays that use flow cytometry to simultaneously quantify multiple soluble analytes in biological samples, available in pre-defined panels and custom configurations.
- ELISA Kits Enzyme-linked immunosorbent assay kits for detection and quantification of specific proteins in biological samples, including LEGEND MAX™ kits.
- FluoroSpot MAX™ Fluorescent spot assay for measuring multiple immune mediators such as IL-10, TNF-α, and IFN-γ in single wells to characterize complex immune responses.
- Flex-T™ MHC Tetramers and Monomers Soluble MHC molecules assembled into tetramers using UV-labile peptide exchange technology for identifying antigen-specific T cells in vaccine development and cancer research.
- Cell-Vive™ GMP Portfolio GMP-grade ancillary materials for cell therapy and ATMP bioprocessing, including antibodies and recombinant proteins compliant with USP<1043> and Ph. Eur. 5.2.12 for downstream manufacturing.
- StarBright™ Dyes Fluorescent dyes powered by Bio-Rad for conventional and spectral flow cytometry applications, licensed for RUO and clinical research use as antibody conjugates.
- Brilliant Violet™ Dyes Proprietary violet laser-excitable fluorescent dyes with minimized polymer dye interactions for multicolor flow cytometry panels.
- XerosFlow™ Lyophilized Cocktails Freeze-dried antibody cocktails with up to 24 months stability at room temperature (20-25°C), formulated with conventional fluorophores, Brilliant Violet™, and StarBright™ dyes to eliminate cold chain requirements.
- Clinical IVD and ASR Reagents In vitro diagnostic products and analyte-specific reagents for clinical laboratory use in immunophenotyping and diagnostic applications, including CE-marked products for the European market and ISO 13485:2016 compliant quality systems.
- Maxpar® Ready Antibodies Antibodies that can be metal-labeled for use in CyTOF® mass cytometry applications.
- Custom Conjugation and Cocktail Services Custom fluorophore and oligo conjugations, plus antibody cocktails in liquid, XerosFlow™ dry, and lyophilized formats, including Brilliant Violet™ and TotalSeq™ options tailored to specific experimental needs.
- Custom ELISA and LEGENDplex™ Immunoassays Custom multiplex immunoassays for quantifying multiple analytes in biological samples, with the ability to combine analytes across multiple kits.
- Contract Manufacturing Services GMP-compliant custom manufacturing for research-grade and bioprocessing-grade materials, including recombinant proteins, monoclonal and recombinant antibodies, cell culture media, and scalable production for cell therapy and bioprocessing applications.
- Flow Cytometry Panel Construction Service Expert panel design and optimization services provided by immunologists and flow cytometry specialists for building optimized multicolor flow cytometry panels.
- Multiomics Analysis Software (MAS) Free cloud-based software for analyzing single-cell RNA and protein data from TotalSeq™ multiomics experiments, designed for users without bioinformatics expertise.
- Fontus™ Cytometry Cocktail Prep Workstation Automated workstation for optimized antibody cocktail preparation and staining, enhancing precision, standardization, productivity, and traceability in clinical flow cytometry, linked with Revvity's clinical IVD product line.
Companies that use BioLegend
Customer profileNamed customers4 records
Segments7 records
Ideal customer profiles4 records
BioLegend technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
BioLegend partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered flagship and core.
- The Michael J. Fox Foundation for Parkinson's ResearchflagshipBioLegend is a participant and sponsor of the MJFF-led Parkinson's Progression Markers Initiative (PPMI), contributing data and samples for NIH AMP program. BioLegend's LEGEND MAX Human α-Synuclein ELISA kit has been used extensively in PPMI multi-centered studies. The partnership was built in collaboration with preeminent neuroscience leaders.
- NIH (National Institutes of Health)flagshipNIH and the Michael J. Fox Foundation partnership program for Parkinson's Disease research as part of the NIH Accelerating Medicines Partnership (AMP). BioLegend contributes as participant and sponsor for the PPMI initiative.
- RevvitycoreBioLegend is now part of Revvity, a health science solutions company (spun off from PerkinElmer in 2023) with 2023 revenue of more than $2.7 billion and over 11,000 employees. Revvity provides complete workflows from discovery to development, and diagnosis to cure, with focus areas in translational multi-omics technologies, biomarker identification, imaging, and diagnostics.
- IlluminacoreCollaboration on BEN-seq workflow developed by BioLegend, where cells in suspension are stained with TotalSeq antibodies prior to bulk RNA sequencing using Illumina platforms. Enables combined protein and RNA analysis in bulk sequencing applications.
- Mission BiocorePartnership for single-cell DNA and protein detection using TotalSeq-D reagents with Mission Bio's Tapestri platform. Enables resolution of complex genetic questions by combining single-cell DNA analysis with protein detection.
- Bio-Rad LaboratoriescorePartnership for StarBright™ dyes (powered by Bio-Rad), fluorescent dyes for flow cytometry applications. StarBright conjugates are available for RUO and clinical research applications according to end user design specifications.
- Revvity (Intra-company)coreCross-selling and integrated product offerings within Revvity family. BioLegend IVD products link to Revvity's Fontus™ Cytometry Cocktail Prep Workstation for automated liquid handling. BioLegend TotalSeq reagents cross-promoted with Revvity single-cell sequencing products.
- 10x GenomicscoreTotalSeq reagents are compatible with 10x Genomics single-cell platforms for simultaneous protein and RNA detection in single-cell RNA sequencing workflows.
- Worldwide DistributorscoreExtensive network of authorized distributors covering over 90 countries. Major regional distributors include Cedarlane (Canada), Nordic Biosite (Nordic countries), Biomedica group (Central/Eastern Europe), and many specialized distributors in Asia-Pacific, Latin America, Middle East, and Africa.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
BioLegend competitors and assessment
Company assessmentDirect peers
- Bio-Rad Laboratories: Bio-Rad is BioLegend's most direct competitor in flow cytometry reagents and is also a technology partner (StarBright™ dyes are powered by Bio-Rad). Both companies sell antibody panels, dyes, and instrumentation consumables to immunology, cancer, and cell biology researchers globally.
- BD Biosciences: BD Biosciences is a leading provider of flow cytometry instruments and reagent kits, including fluorescent antibodies, multiplex bead arrays, and clinical IVD flow cytometry products. It directly competes with BioLegend in clinical and research flow cytometry and is a global incumbent in the installed-instrument base.
- Miltenyi Biotec: Miltenyi Biotec is a global competitor in magnetic cell separation (MACS®), flow cytometry reagents, and cell therapy manufacturing reagents — directly competing with BioLegend's MojoSort™ and cell-therapy-adjacent reagent portfolio. It has built an end-to-end cell therapy manufacturing offering that parallels Cell-Vive™.
- Cell Signaling Technology (CST): CST is a leading provider of highly validated antibodies and reagents, with a strong reputation in cell signaling, cancer, and neuroscience research — directly comparable to BioLegend's content library and validation-led positioning. CST competes on antibody specificity, reproducibility, and application support across Western blot, IHC, and flow cytometry.
- Bio-Techne (R&D Systems / Novus Biologicals / Tocris): Bio-Techne is a major competitor in recombinant proteins, cytokines/growth factors, ELISA kits, and research antibodies (via R&D Systems, Novus, and Tocris). It overlaps directly with BioLegend's recombinant protein and immunoassay businesses, including in GMP and cell therapy reagent adjacencies.
- Abcam: Abcam is one of the largest research antibody catalog businesses globally, offering polyclonal, monoclonal, and recombinant antibodies across essentially the same research applications as BioLegend (flow cytometry, IHC, Western blot, IF). It is a direct horizontal competitor in catalog antibody breadth and pricing.
- Cytek Biosciences: Cytek is a leading provider of spectral flow cytometry instruments and reagents; it directly competes with BioLegend in advanced flow cytometry workflows and benefits from instrument–reagent cross-selling similar in concept to BioLegend's Brilliant Violet™ and StarBright™ reagent strategies.
Broad incumbents
- Thermo Fisher Scientific (Invitrogen / eBioscience / Gibco): Thermo Fisher's life sciences brands (Invitrogen, eBioscience, Gibco, Thermo Scientific) offer an overlapping portfolio of research antibodies, recombinant proteins, cell culture reagents, and flow cytometry consumables. As a large incumbent, it competes with BioLegend across most catalog reagent categories and benefits from a much broader instrument and services footprint.
Emerging players
- 10x Genomics: 10x Genomics is BioLegend's single-cell sequencing platform partner (TotalSeq™ is compatible with 10x workflows) and an emerging adjacent player in single-cell multiomics reagents. It is a peer in the broader single-cell ecosystem where strategic choices by 10x can materially affect TotalSeq™'s positioning.
- Standard BioTools (formerly Fluidigm): Standard BioTools markets the CyTOF®/Hyperion® mass cytometry platform and Maxpar® metal-tagged antibody panel reagents — BioLegend sells Maxpar® Ready antibodies into the same workflow, making Standard BioTools a partially overlapping player in high-parameter cellular profiling.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
BioLegend social profiles
Digital presenceBioLegend compliance and trust
Trust signalCompliance2 records
BioLegend financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioLegend leadership team
Management profileNumber of profiles
Profiles3 records
BioLegend subsidiaries and ownership
Company hierarchySubsidiaries4 records
BioLegend funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioLegend M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioLegend
What does BioLegend do?
BioLegend develops, manufactures, and distributes a catalog of thousands of antibody-based reagents for life science research, including flow cytometry antibodies, recombinant proteins (cytokines, growth factors, chemokines), multiplex immunoassays (LEGENDplex™), ELISA kits, and MojoSort™ magnetic cell separation products. The portfolio is anchored by proprietary platforms such as TotalSeq™ oligo-conjugated antibodies for single-cell proteogenomics, Flex-T™ MHC tetramers for antigen-specific T cell detection, and GMP-grade Cell-Vive™ ancillary materials for cell therapy bioprocessing, complemented by custom conjugation services and contract manufacturing for research and clinical applications.
Is BioLegend a public or private company?
BioLegend is a private company. It is classified as corporate owned and is currently operating.
When was BioLegend founded?
BioLegend was founded in 2002. It employs 501 to 1,000 people.
Where is BioLegend based?
BioLegend is headquartered in San Diego, United States, in the North America region.
How does BioLegend make money?
Six revenue lines are on record. Research Antibodies and Reagents are the primary driver. The others are recombinant Proteins and Cytokines, immunoassays (ELISA and LEGENDplex™), custom Reagents and Conjugation Services, custom Manufacturing Services and clinical Diagnostics (IVD and ASR).
Who are BioLegend's main competitors?
Direct peers on record are Bio-Rad Laboratories, BD Biosciences, Miltenyi Biotec, Cell Signaling Technology (CST), Bio-Techne (R&D Systems / Novus Biologicals / Tocris), Abcam and Cytek Biosciences. Thermo Fisher Scientific (Invitrogen / eBioscience / Gibco) is listed as a broad incumbent. Emerging players are 10x Genomics and Standard BioTools (formerly Fluidigm).
Does BioLegend have an API?
No public API is recorded for BioLegend.
What industry is BioLegend in?
BioLegend's product category is Life Science Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 325414 and its SIC code is 2836.